Skip to main content

. 1989 Oct 21;299(6706):1012–1013. doi: 10.1136/bmj.299.6706.1012

Non-biological factors in day to day variation of heparin requirements.

A G Fennerty ¹, M N Levine ¹

PMCID: PMC1837883 PMID: 2511942

1012

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Crass R. E., Vance J. R. In vivo accuracy of gravity-flow i.v. infusion systems. Am J Hosp Pharm. 1985 Feb;42(2):328–331. [PubMed] [Google Scholar]
Fennerty A., Campbell I. A., Routledge P. A. Anticoagulants in venous thromboembolism. BMJ. 1988 Nov 19;297(6659):1285–1288. doi: 10.1136/bmj.297.6659.1285. [DOI] [PMC free article] [PubMed] [Google Scholar]
van den Besselaar A. M., Meeuwisse-Braun J., Jansen-Grüter R., Bertina R. M. Monitoring heparin therapy by the activated partial thromboplastin time--the effect of pre-analytical conditions. Thromb Haemost. 1987 Apr 7;57(2):226–231. [PubMed] [Google Scholar]

ACTIONS

RESOURCES